A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2004
12/09/2004	US20040248233 Using propyl hydroxylase expression system to identify modulators which interfere with or prevent generation of hypoxic states; screening modulator for treatment and prevention of cell proliferative and thrombotic disorder
12/09/2004	US20040248231 Using reduction in beta site amyloid precursor protein cleaving enzyme activity, manifested as decreased beta amyloid peptides production, as diagnostic indicator of enzyme inhibition; for use in treatment of amyloid deposition disorders
12/09/2004	US20040248220 Using cadherin expression as diagnostic and prognostic indicator of tumor cell expression and/or progression
12/09/2004	US20040248219 Methods for diagnosing and evaluating cancer
12/09/2004	US20040248218 Gene SCC-112 and diagnostic and therapeutic uses thereof
12/09/2004	US20040248211 Hybridoma cell line comprising intracellular adhesion molecules for use in generating immunoglobulins to treatment autoimmune, skin and inflammatory disorders
12/09/2004	US20040248209 Identifying modulators which modify binding activity of isoprenoids and membrane protein receptors for use in treatment of diabetes, obesity, pain, inflamatory, cardiovascular, cancer and liver disorders
12/09/2004	US20040248207 Sodium channel regulators and modulators
12/09/2004	US20040248201 Recognition molecules interacting specifically with the active site or cleft of a target molecule
12/09/2004	US20040248192 Composition
12/09/2004	US20040248188 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/09/2004	US20040248184 Regeneration protein for use in diagnosis, prevention and treatment of diabetes and cardiovascular disorders; antidiabetic agents
12/09/2004	US20040248178 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders
12/09/2004	US20040248175 Embryogenic regulatory protein for use in diagnosis, prevention and treatment of cell proliferative and reproductive disorders
12/09/2004	US20040248166 Nucleotide sequences coding peptide receptor for use as tools in diagnosis, prevention and treatment of cancer, arthritis or viral infection
12/09/2004	US20040248164 Preparing microarray comprised of short hairpin looped RNA molecules for use in monitoring gene expression in mammalian cells; high throughput assay for use in functional genomics; post transcriptional gene silencing
12/09/2004	US20040248160 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor
12/09/2004	US20040248156 Nucleotide sequences coding complement pathway protein domains for use in diagnosis and treament of viral infection, inflammation, diabetes, immune and lipid metabolism disorders
12/09/2004	US20040248145 Using vector transformation to generate transgenic cells which overexpress an enzyme which specifically digests RNA/DNA hybrids; gene expression inhibition via nuclease digestion and antisense oligonucleotide exposure
12/09/2004	US20040248138 Human angiomotin-like protein 1
12/09/2004	US20040248137 Human and mammalian stem cell-derived neuron survival polypeptides
12/09/2004	US20040248124 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
12/09/2004	US20040248114 Novel maxizyme
12/09/2004	US20040248099 Calcium-activated potassium channels; 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives act as inhibitors; gene knockout; skin disorders; psoriasis; wound healing
12/09/2004	US20040248091 Novel polypeptide-human g-protein and the polynucleotide encoding the same
12/09/2004	US20040248088 Novel g protein-coupled receptor up-regulated in prostate cancer and uses thereof
12/09/2004	US20040247691 wound healing and tissue forming compositions with suitable cells affixed to prosthetic devices; microbeads are prepared by coagulation and emulsification of fibrinogen, thrombin and factor XIII without gluteraldehyde as a crosslinking agent
12/09/2004	US20040247671 Solid drug formulation and device for storage and controlled delivery thereof
12/09/2004	US20040247662 Systemic immune activation method using nucleic acid-lipid complexes
12/09/2004	US20040247661 injectable liposomal composition for delivery of large amounts of water-soluble substance comprises a plurality of liposomal vesicles having a high weight ratio of lipid to encapsulated water-soluble substance which is distributed over the liposomal vesicles; high efficiency of encapsulation
12/09/2004	US20040247623 Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin
12/09/2004	US20040247621 Combination therapy using a synergistic mixture of mechlorethamine, nitrogen mustard N-oxide, melphalan, uramustin, ifosfamide, chlorambucil, or cyclophosphamide and an anti-interleukin-6 receptor antibody; anticarcinogenic agents
12/09/2004	US20040247619 Therapeutic composition including saw palmetto for cancer treatment
12/09/2004	US20040247618 Nutrient absorption enhancing compositions and methods
12/09/2004	US20040247616 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof
12/09/2004	US20040247615 A nucleic acid comprising a nucleotide sequence encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region; adenovector or DNA plasmid vaccine; cultured cells expressing the nucleic acid; vaccination
12/09/2004	US20040247613 A nucleic acid expression vector encodes the catalytic subunit of human telomerase reverse transcriptase (hTRT); immunostimulants; anticarcinogenic agents; gene therapy
12/09/2004	US20040247612 Immunogenic peptide composition for the prevention and treatment of Alzheimer's Disease
12/09/2004	US20040247606 Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections
12/09/2004	US20040247605 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
12/09/2004	US20040247603 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation
12/09/2004	US20040247599 Modulators of the P2Y10 receptor useful in altering T lymphocyte function
12/09/2004	US20040247598 In particular of delayed-type hypersensitivity; especially administering an IL-18 binding protein or a derivative, an expression vector or a genetically engineered cell, optionally with an antiinflammatory agent such as a COX-inhibitor.
12/09/2004	US20040247596 TRANCE regulation of chondrocyte differentiation
12/09/2004	US20040247595 Related to the potassium channel subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity
12/09/2004	US20040247592 Administering a substance that modulates an ephrin or an Eph receptor, especially treating cancer by modulating an adhesive, migratory or chemotactic property of a cancer cell; also treating autoimmune diseases, allergies, graft versus host disease, and transplant rejection
12/09/2004	US20040247589 More particularly from the serum of alligators or crocodiles; active proteins obtained from the sera show no overt toxicity in healthy mammals, and may therefore be used for the prevention, investigation, treatment or diagnosis of cancer
12/09/2004	US20040247586 Parkin-associated complex for protecting post-mitotic neurons from excitotoxicity and uses thereof
12/09/2004	US20040247585 Recombinant alpha-galactosidase a therapy for fabry disease
12/09/2004	US20040247584 Administering an atypical form of protein kinase C, such as PKM zeta or PKC iota/lambda; also treating brain and spinal cord injuries
12/09/2004	US20040247579 Mixed chimerism and tolerance
12/09/2004	US20040247578 Administering into or near a site of a tumor or infectious lesion an antigen presenting cell, especially a dendritic cell, and an immunostimulatory cytokine or a nucleic acid encoding an immunostimulatory cytokine
12/09/2004	US20040247567 Transfecting cells of the free flap ex vivo by perfusing with a suspension of a vector that is a nucleic acid encoding the product of interest under the control of a promoter; and reattaching the free flap to the native circulation using microvascular surgical techniques.
12/09/2004	US20040247566 Having at least one amino-acid substitution and including multimers and Fc-fusion constructs; treating a human lung disorder such as chronic obstructive pulmonary disorder, asthma, emphysema, and chronic bronchitis
12/09/2004	US20040247565 Oral administration, for modulating the IL-10/IL-12 blood ratio to treat autoimmune disorders such as Type I diabetes, rheumatoid arthritis, lupus, psoriasis, Myasthenia Gravis, Graves' disease, Hashimoto's thyroiditis, Sjogren's syndrome, ankylosing spondylitis and inflammatory bowel disease
12/09/2004	US20040247564 Treating a tissue disorder involving a loss and/or apoptosis of cells by administering an agent that induces phosphorylation and/or activation of protein kinase B to cause proliferation; particularly administering a human stromal-derived factor-1 and a G-CSF to cause proliferation of cardiomyocytes
12/09/2004	US20040247563 Method of enhancing lymphocyte-mediated immune responses
12/09/2004	US20040247537 Uv-screening peptide-flavonoid conjugates
12/09/2004	US20040247529 Administering a pulmonary surfactant preparation, including a phosphatide and/or a surfactant protein to artificially respirate a patient suffering from a toxic oxygen concentration; side effect reduction
12/09/2004	US20040244806 Treating disc herniation and other conditions with leukocytes
12/09/2004	DE102004012273A1 Stabile und geschmacksmaskierte pharmazeutische Dosierungsform unter Verwendung von porösen Apatit-Körnern Stable and taste masked pharmaceutical dosage form using porous apatite grains
12/09/2004	CA2527795A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines
12/09/2004	CA2527772A1 Tumor-targeted drug delivery systems and uses thereof
12/09/2004	CA2527743A1 Stabilized pharmaceutical peptide compositions
12/09/2004	CA2527722A1 Biodegradable poly(beta-amino esters) and uses thereof
12/09/2004	CA2527438A1 P-selectin targeting ligand and compositions thereof
12/09/2004	CA2527429A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
12/09/2004	CA2527382A1 Captopril derivatives
12/09/2004	CA2527309A1 Use of protein associated with mye (pam) to treat pain
12/09/2004	CA2527186A1 Compositions comprising gastrin compounds and their use in diabetes
12/09/2004	CA2527039A1 Grf analog compositions and their use
12/09/2004	CA2526623A1 Soluble clca-1 and antagonists to clca-1
12/09/2004	CA2526083A1 Complement inhibitors
12/09/2004	CA2525717A1 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
12/09/2004	CA2524755A1 Unitary combination of fsh and hcg
12/09/2004	CA2523774A1 Deer antler extract for promoting angiogenesis
12/08/2004	EP1484405A1 Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
12/08/2004	EP1484404A1 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
12/08/2004	EP1484402A2 Antibody for use in therapy
12/08/2004	EP1484401A1 Secreted polypeptides and corresponding polynucleotides
12/08/2004	EP1484400A1 Sodium-independent transporter carrying acidic amino acid and its gene
12/08/2004	EP1484393A1 Polynucleotide for target gene
12/08/2004	EP1484340A1 Antibodies to a novel mammalian protein associated with uncontrolled cell division
12/08/2004	EP1484339A2 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same
12/08/2004	EP1484338A1 Methods and compositions for inhibiting neoplastic cell growth
12/08/2004	EP1484336A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines
12/08/2004	EP1484335A1 23 human secreted proteins
12/08/2004	EP1484081A1 Systems and methods for treating ischemia
12/08/2004	EP1484080A1 Biodegradable, anionic polymers
12/08/2004	EP1484067A2 Cancer control
12/08/2004	EP1484066A1 Remedy for infections
12/08/2004	EP1484063A2 Method for inhibiting rejection of transplanted tissue
12/08/2004	EP1484059A2 Antiviral composition comprising phenylacetic acid derivatives
12/08/2004	EP1484058A2 Pharmaceutical composition for inhibiting altering gene expression and for inducing differentiation in non-malignant cells
12/08/2004	EP1483588A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
12/08/2004	EP1483575A2 Methods for isolating ligands e.g. t cell epitopes
12/08/2004	EP1483561A2 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor
12/08/2004	EP1483397A2 Oligomeric molecules and uses thereof
12/08/2004	EP1483396A2 Wit 3.0, novel gene to control soft tissue wound healing
12/08/2004	EP1483389A2 Genetic products differentially expressed in tumors and use thereof

1 ... 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 ... 3163